Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.3411
-0.0029 (-0.84%)
At close: Sep 12, 2025, 4:00 PM EDT
0.3600
+0.0189 (5.54%)
After-hours: Sep 12, 2025, 7:52 PM EDT
Co-Diagnostics Stock Forecast
CODX's stock price has decreased by -72.93% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts that cover Co-Diagnostics stock have a consensus rating of "Buy" and an average price target of $5.50, which forecasts a 1,512.43% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $10.
Price Target: $5.50 (+1,512.43%)
Analyst Consensus: Buy
* Price targets were last updated on Aug 15, 2025.
Analyst Ratings
The average analyst rating for Co-Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +2,831.69% | Aug 15, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +2,831.69% | Apr 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $1.5 → $1 | Hold | Maintains | $1.5 → $1 | +193.17% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1.5 | Hold | Reiterates | $1.5 | +339.75% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $2 → $1.5 | Hold | Maintains | $2 → $1.5 | +339.75% | Aug 12, 2024 |
Financial Forecast
Revenue This Year
523.26K
from 3.92M
Decreased by -86.64%
Revenue Next Year
688.50K
from 523.26K
Increased by 31.58%
EPS This Year
-0.74
from -1.24
EPS Next Year
-0.45
from -0.74
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 853,650 | 1.4M | |||
| Avg | 523,260 | 688,500 | |||
| Low | 208,740 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -78.2% | 171.0% | |||
| Avg | -86.6% | 31.6% | |||
| Low | -94.7% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.70 | -0.41 | |||
| Avg | -0.74 | -0.45 | |||
| Low | -0.77 | -0.49 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.